Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals

被引：0
|
作者：
Kathryn J. Eagye
David P. Nicolau
机构：
[1] Hartford Hospital,Center for Anti
[2] Hartford Hospital,Infective Research and Development
[3] Hartford Hospital,Center for Anti
来源：
Advances in Therapy | 2011年 / 28卷
关键词：
antimicrobial resistance; fluoroquinolones; imipenem;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：326 / 333
页数：7
相关论文
共 50 条
  • [1] Fluoroquinolone Use Is not Associated with the Change in Imipenem Susceptibility of Pseudomonas aeruginosa in 25 Hospitals
    Eagye, Kathryn J.
    Nicolau, David P.
    ADVANCES IN THERAPY, 2011, 28 (04) : 326 - 333
  • [2] Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in US hospitals
    Bhavnani, SM
    Callen, WA
    Forrest, A
    Gilliland, KK
    Collins, DA
    Paladino, JA
    Schentag, JJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2003, 60 (19) : 1962 - 1970
  • [3] Fluoroquinolone use and fluoroquinolone-resistant Pseudomonas aeruginosa is declining in US academic medical centre hospitals
    Pakyz, Amy L.
    Lee, Jin A.
    Ababneh, Mera A.
    Harpe, Spencer E.
    Oinonen, Michael J.
    Polk, Ron E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (06) : 1562 - 1564
  • [4] The Impact of Ertapenem Use on the Susceptibility of Pseudomonas aeruginosa to Imipenem: A Hospital Case Study
    Lima, Ana Lucia L.
    Oliveira, Priscila R.
    Paula, Adriana P.
    Dal-Paz, Karine
    Rossi, Flavia
    Zumiotti, Arnaldo V.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (05): : 487 - 490
  • [5] Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa
    Higgins, PG
    Fluit, AC
    Milatovic, D
    Verhoef, J
    Schmitz, FJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (02) : 299 - 300
  • [6] Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use
    MacDougall, C
    Harpe, SE
    Powell, JP
    Johnson, CK
    Edmond, MB
    Polk, RE
    EMERGING INFECTIOUS DISEASES, 2005, 11 (08) : 1197 - 1204
  • [7] Rapid detection of imipenem/relebactam susceptibility/resistance in Pseudomonas aeruginosa
    Bouvier, Maxime
    Bachtarzi, Mohamed
    Poirel, Laurent
    Nordmann, Patrice
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2024, 110 (04)
  • [8] Effects of hyperbaric oxygen on Pseudomonas aeruginosa susceptibility to imipenem and macrophages
    Lima, Flavia Luna
    Joazeiro, Paulo Pinto
    Lancellotti, Marcelo
    de Hollanda, Luciana Maria
    Lima, Bruna de Araujo
    Linares, Edlaine
    Augusto, Ohara
    Brocchi, Marcelo
    Giorgio, Selma
    FUTURE MICROBIOLOGY, 2015, 10 (02) : 179 - 189
  • [9] Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities
    Polk, RE
    Johnson, CK
    McClish, D
    Wenzel, RP
    Edmond, MB
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) : 497 - 503
  • [10] Inactivation of nfuA enhances susceptibility of Pseudomonas aeruginosa to fluoroquinolone antibiotics
    Daung-nkern, Jintana
    Vattanaviboon, Paiboon
    Mongkolsuk, Skorn
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (08) : 1831 - 1832
12345